The trajectory of Sildenafil presents a interesting case for stakeholders in the medicinal sector. While initially a blockbuster success, generating billions, the exclusivity end and the subsequent arrival of off-brand https://pharma632688.bloggazzo.com/40468175/viagra-and-the-pharmaceutical-industry-a-speculative-bet